×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GCTK – glucotrack, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GCTK
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/30
06:01 pm
gctk
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
3/30
05:07 pm
gctk
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights [TheStreet.com]
Medium
Report
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights [TheStreet.com]
3/30
04:50 pm
gctk
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Medium
Report
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
3/28
12:10 am
gctk
Microcap MedTech Moving on U.S. Clinical Milestone [Globe and Mail, The (Toronto, Canada)]
Medium
Report
Microcap MedTech Moving on U.S. Clinical Milestone [Globe and Mail, The (Toronto, Canada)]
3/27
10:09 pm
gctk
Glucotrack to File for FDA Exemption Based on 2025 Milestones [Yahoo! Finance]
Medium
Report
Glucotrack to File for FDA Exemption Based on 2025 Milestones [Yahoo! Finance]
3/27
08:07 am
gctk
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones [Yahoo! Finance]
High
Report
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones [Yahoo! Finance]
3/27
08:01 am
gctk
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones
High
Report
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones
3/10
08:01 am
gctk
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit
Low
Report
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/30
05:43 pm
gctk
Form 10-K Glucotrack, Inc. For: Dec 31
Medium
Report
Form 10-K Glucotrack, Inc. For: Dec 31
3/30
05:42 pm
gctk
Form 8-K Glucotrack, Inc. For: Mar 30
Medium
Report
Form 8-K Glucotrack, Inc. For: Mar 30
3/27
08:25 am
gctk
Form 8-K Glucotrack, Inc. For: Mar 27
High
Report
Form 8-K Glucotrack, Inc. For: Mar 27
3/13
04:05 pm
gctk
Form 8-K Glucotrack, Inc. For: Mar 12
Medium
Report
Form 8-K Glucotrack, Inc. For: Mar 12
2/17
09:50 pm
gctk
Form SCHEDULE 13G Glucotrack, Inc. Filed by: ARMISTICE CAPITAL, LLC
Medium
Report
Form SCHEDULE 13G Glucotrack, Inc. Filed by: ARMISTICE CAPITAL, LLC
2/17
05:23 pm
gctk
Form SCHEDULE 13G Glucotrack, Inc. Filed by: Ikarian Capital, LLC
Low
Report
Form SCHEDULE 13G Glucotrack, Inc. Filed by: Ikarian Capital, LLC
2/9
04:05 pm
gctk
Form DEF 14A Glucotrack, Inc. For: Feb 09
Low
Report
Form DEF 14A Glucotrack, Inc. For: Feb 09
1/29
05:17 pm
gctk
Form PRE 14A Glucotrack, Inc. For: Jan 29
High
Report
Form PRE 14A Glucotrack, Inc. For: Jan 29
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: